FGF9 has been shown to be dysregulated in ovarian endometrioid adenocarcinoma [22], hepatocellular carcinoma [23], prostate carcinoma [24] and GC [12]. The gene discussed is FGF9; the disease is ovarian endometrioid adenocarcinoma.